Introduction
The cDNA encoding a 96 kd mitogen-responsive phosphoprotein with homology to Drosophila Disabled (dDab) was cloned recently from a mouse macrophage library (Xu et al., 1995) , and is referred to herein as . [DOC2 (Dierentially-expressed in Ovarian Carcinoma 2), is the name giving to a 782 base pair fragment of human Dab2 in a dierent expression screening study by Mok et al. (1994) . Dab1, another murine homolog of dDab was cloned by B Howell, JA Cooper and colleagues at Fred Hutchinson Cancer Center (personal communication, the cloning of Dab1 has been submitted for publication). Like dDab, Dab1 is expressed mainly in the nerve system. Although the murine Dab2 sequence (known as mitogen responsive protein p96) appeared in the literature ®rst (Xu et al., 1995) , we have agreed on naming the protein identi®ed in Cooper's lab as Dab1, and the 96 kd protein cloned by us as Dab2, since Dab1 has similar pattern of expression as dDab and may therefore be the functional homolog of dDab.] dDab was previously identi®ed as a second site modi®er of an Ab1 kinase mutation (Homann, 1991; Gertler et al., 1989; . Together these two mutations are lethal at the embryonic stage due to defective neural development. Aected¯y embryos exhibit disrupted axon connections in the central nerve system and defective muscle ®bre attachment to the body wall. dDab is expressed predominantly in neural tissues. In contrast, Dab2 appears to be widely distributed (Xu, unpublished data) . Although the function of Dab2 is unknown, it has been speculated that it functions as a negative growth regulator, based on its loss in ovarian tumor tissue and cell lines (Mok et al., 1994; Wong et al., 1993; and Xu, unpublished data) .
The sequences of¯y and mammalian Dab homologs suggest that they participate in signal transduction. dDab and Dab2 contain a phosphotyrosine interaction domain (PID, or PTB) domain within the N-terminal 140 amino acids (Bork and Margolis, 1995) . Similar to SH2 domains, the PID domain of Shc and other proteins has been shown to bind phosphotyrosine residues within the context of speci®c amino acid sequences (Kavanaugh and Williams, 1994; Blaikie et al., 1994; Pawson, 1994) . Dab2 also contains a C-terminal proline-rich domain, the sequence of which resembles the proline-rich motifs contained in Sos (Bowtell et al., 1992; Chardin et al., 1993) , a guanine nucleotide exchange factor for Ras (Scheme I).
Scheme I
These proline-rich sequences in Sos function to bind Grb2, an adaptor protein which contains one SH2 domain and two¯anking SH3 domains (Lowenstein et al., 1992; Matuoka et al., 1992) . SH3 domains, a structure often found in signaling molecules, mediate protein-protein interactions by binding to proline-rich sequences in their binding partners (Ren et al., 1993) .
The critical amino acids of the proline-rich sequence for binding to both C-and N-terminal SH3 domains of Grb2 have been elicited (Feng et al., 1994; Lim et al., 1994; Wittekind et al., 1994) , and are shown by arrows in Scheme I. Binding of either SH3 domain of Grb2 to Sos requires a polyproline type II helix with a consensus sequence of XPXXPXR. Other proteins such as Gab1 (Holgado-Madruga et al., 1996) and Dynamin (Miki et al., 1994) that also interact with high anity with Grb2 contain such a consensus proline-rich sequence. Because Dab2 also contains this consensus sequence, we herein have investigated the possibility that Dab2 is a binding partner of Grb2. We report that Dab2 associates with Grb2 in vivo and in vitro. The binding is mediated through the interaction between both SH3 domains of Grb2 and the prolinerich sequences of Dab2. Thus, Dab2 is a new SH3 domain-binding partner of Grb2, which may de®ne a new pathway branching out of Grb2, or Dab2 could be a regulator for Ras activation by controlling Grb2 binding to Sos.
Results

Co-immunoprecipitation of Dab2 and Grb2 from cell lysate
We investigated the interaction of Dab2 with Grb2 in a CSF-1 dependent murine macrophage-like cell line, BAC1.2F5, which was previously shown to express Dab2 (Xu et al., 1995) . The BAC1.2F5 cell lysate contained Dab2, Sos and Grb2, based on Western blotting with speci®c antisera (Figure 1 ). An antiserum to Dab2, but not the pre-immune serum, immunoprecipitated Dab2, and Grb2, but not Sos, was coimmunoprecipitated. Immunoprecipitation of Grb2 using Grb2 speci®c antibodies precipitated both Dab2 and Sos (Figure 1 ), whereas an anti-Sos antibody immunoprecipitated both Sos and Grb2 but not Dab2. These results indicate that Sos and Dab2 associate with Grb2 in separate complexes.
To determine whether the association of Dab2 with Grb2 is aected by activation of the growth factor signaling pathway, the association of Grb2 with CSF-1 receptor (c-Fms) was compared with the association of Grb2 with Dab2 in the absence and presence of CSF-1. The CSF-1 receptor is similar in structure to the PDGF receptor, and undergoes autophosphorylation on speci®c tyrosines in response to CSF-1 binding. Grb2 binds to the phosphorylated tyrosine residue on the CSF-1 stimulated, activated receptor through its SH2 region (Lioubin et al., 1995; van der Geer and Hunter, 1993) . As shown in Figure 2 , Grb2 coimmunoprecipitated with the CSF-1 receptor (c-Fms) only upon stimulation with CSF-1 (+) and in nonsynchronized (NS) cells which were grown continuously in the presence of CSF-1, but not in G1-arrested cells (7) in which c-Fms is not phosphorylated. Unlike c-Fms, Dab2 associates with Grb2 equally well in the absence and presence of CSF-1. Grb2 also coimmunoprecipitated with Dab2 in non-synchronized (NS) cells. Dynamin, another protein which binds the SH3 domains of Grb2 in vitro (Wang and Moran, 1996; Miki et al., 1994) , was not detected in the immunoprecipitate (data not shown).
Dab2 competes with Sos for Grb2 binding in vivo
Human kidney ®broblast 293 cells were used to determine whether the presence of Dab2 interferes with the binding of Sos to Grb2. This cell line contains no detectable Dab2. Upon transfection, Dab2 was expressed to high levels (3 ± 5-fold greater than the level detected in BAC1.2F5 cells), while levels of Grb2 and Sos in a total cell lysate were similar between Dab2-transfected and vector-transfected cells (not shown). In Dab2-transfected cells, anti-Grb2 antibodies immunoprecipitated a similar amount of Grb2 as in the Dab2-negative cells (transfected with empty vector). However, co-immunoprecipitation of Sos with Grb2 was greatly reduced, while signi®cant co-immunoprecipitation of Dab2 was seen (Figure 3) . Thus, expressed Dab2 competes with Sos for binding to Grb2. 
Grb2
Immunoprecipitation Figure 1 Co-immunoprecipitation of Grb2 with Dab2 and with Sos. BAC1.2F5 macrophages were grown in 25% L cellconditioned medium which contains CSF-1. Cells were lysed in Lysis Buer as described in Experimental Procedures, and the lysate (5 mg protein in 1 ml) was immunprecipitated (IP) using antibodies against Grb2, Sos, and Dab2, or irrelevant pre-immune antibodies (Pre-). The cell lysate and the immunocomplexes were fractionated on 12% SDS gels for analysis by Western blotting with anti-Grb2, and on 7.5% gels for analysis using anti-Sos and anti-Dab2 antibodies as indicated
Figure 2 Grb2 binds to Dab2 independently of growth factor stimulation. BAC1.2F5 cells were arrested at G1 by culturing in medium without CSF-1 for 18 h, and the cells were stimulated with CSF-1 (3000 unit/ml) for 5 min. Cells which had been growth-arrested (7), CSF-re-stimulated (+), and non-synchronized (NS, which had been grown in the presence of CSF-1 at all times) were lysed in Lysis Buer. The lysate (10 mg protein in 1 ml) was immunoprecipitated (IP) using antibodies against Dab2, the CSF-1 receptor (c-Fms), or irrelevant antibodies (Pre). The immunocomplexes were separated on 12% gels and were analysed by Western blotting with anti-Grb2 antibodies (1/ 1000 dilution, Signal Transduction Lab)
Proline-rich peptides compete with Dab2 for binding to Grb2
The interaction between Grb2 and Dab2 was investigated in vitro using an expressed GST-fusion protein of Grb2. GST-Grb2 bound to glutathione Sepharose beads was incubated with BAC1.2F5 cell lysates, and cellular proteins bound to the beads were then analysed by SDS ± PAGE and Western blotting. Figure 4 , lower panel). The Dab2 peptide was more eective than the mSos1 peptide in inhibiting complex formation between GST-Grb2 and Dab2. Both peptides also inhibited the binding of GST-Grb2 to Sos, but were much less potent in disrupting this interaction than the GST-Grb2/Dab2 interaction. Thus, proline-rich peptides from both Dab2 and Sos1 interfered with the binding of Dab2 to Grb2.
The proline-rich domain of Dab2 is sucient for binding to Grb2
To analyse the region on Dab2 which interacts with Grb2, truncated forms of Dab2 were expressed as GST fusion proteins (Figure 5a 
Intact Grb2, but not individual SH3 domains, Binds Dab2
The binding of Dab2 to Grb2 in vitro was further examined using expressed GST fusion proteins consisting of the full length Grb2 and various truncation mutants comprised of the individual SH2 domain and fragments containing each SH3 domains. The expressed proteins were puri®ed on glutathione columns, and the prepared material is shown in Figure  6a , left panel. GST fusion proteins were then incubated with a lysate from BAC1.2F5 cells as above, and associated proteins were analysed by SDS ± PAGE and Western blotting. The full-length GST-Grb2, but not GST itself, bound Dab2 from a BAC1.2F5 cell lysate . While the SH2 domain failed to bind Sos, both the C-and N-terminal SH3 domains of Grb2 bound mSos1, with the N-terminal SH3 domain being more eective than the C-terminal domain, similar to results published previously (Egan et al., 1993; Rozakis-Adcock et al., 1993; Li et al., 1993; Buday and Downward, 1993) . The constructs of the Grb2 fusion protein and results of this experiment are illustrated in Figure 6b . High anity binding to Dab2 appears to require the intact Grb2 structure. Thus, we suggest that the two SH3 domains of Grb2 function in a cooperative manner to bind to the proline-rich domain of Dab2.
Binding of phosphopeptide to Grb2 reduces its anity to Dab2
Despite many attempts, we have failed to detect the association of Dab2 with the CSF-1 receptor or the EGF receptor (data not shown), although signi®cant quantities of Grb2 are associated in vivo with Dab2. To explore the reason that the Dab2/Grb2 complex is not associated with the tyrosine phosphorylated receptor, we have investigated the eect of ligand binding to the SH2 domain of Grb2 on its anity to Dab2. We have taken advantage of an earlier study using phosphotyrosine peptides corresponding to the sequence surrounding the eight tyrosine residues in the cytoplasmic domain of the erythropoietin receptor (Yi et al., 1995) . Among these eight phosphopeptide, PY 488 (SHPY*ENSLVPD, * for phosphate, corresponding to murine erythropoietin receptor amino acid #485-495) is the only peptide that binds Grb2 (data not shown). PY488 conjugated beads precipitated cellular Grb2 and associated Sos, but not Dab2 (Figure 7a ). In addition, PY488 peptide, but not un-phosphorylated Y488, inhibits GST-Grb2 binding to Dab2, but does not inhibit GST-Grb2 binding to cellular Sos (Figure 7b ). Thus, binding of tyrosine phosphorylated growth factor receptor to the SH2 domain of Grb2 may in¯uence the anity of Grb2 SH3 domains to Dab2.
Discussion
Sos is the best characterized binding partner for the SH3 domains of Grb2 (Mayer and Baltimore, 1993; Binding of cellular Grb2 to GST fusion proteins of the Dab2 proline-rich domain. DNA constructs for GST fusion proteins of the phosphotyrosine interacting domain (PID, amino acids 1 ± 233), middle region (M15, amino acids 335 ± 610), and proline-rich domain (PRD, amino acids 600 ± 730) of Dab2 were prepared by PCR approach using the murine Dab2 cDNA as template. The fusion proteins were expressed in E. coli and puri®ed as described in the Materials and methods. An aliquot of each puri®ed GST fusion protein (about 10 mg) was analysed for protein purity by separating in a SDS gel and staining the gel with Coomassie Blue (a, left panel). BAC1.2F5 cell lysate (5 mg protein in 1 ml) was incubated with the glutathione bead-conjugated GST fusion proteins (50 mg protein). Bound cellular proteins were analysed by SDS ± PAGE followed by Western blot with antiGrb2 antibody (a, right panel). (b) The fusion protein constructs and results of the experiment are illustrated Pawson, 1994; Pawson and Schlessinger, 1993) . However, it is estimated that there is 3 ± 10 times more Grb2 than Sos in cells (Downward, 1994; Chardin et al., 1995) . Binding partners for SH3 domains of Grb2 other than Sos have been described, including dynamin (Wang and Moran, 1996; Miki et al., 1994) , C3G (Tanaka et al., 1994) , synapsin (McPherson et al., 1994), 5-lipoxygenase (Lepley and Fitzpatrick, 1994) , and Gab1 (Holgado-Madruga et al., 1996) . In principle, these proteins may function either in pathways down-stream of Grb2 which are parallel or analogous to the Sos pathway, or as regulators of the Sos/Grb2 interaction. Several Grb2 functions other than Sos binding and Ras activation have been suggested: binding of dynamin to Grb2 is thought to be required for the endocytosis of the EGF receptor (Wang and Moran, 1996) ; binding to C3G, another Ras guanine nucleotide exchange factor, is a parallel pathway to that of Sos for Ras activation (Tanaka et al., 1994) ; binding to Gab1 may de®ne a Rasindependent pathway which could lead to cell proliferation and transformation (Holgado-Madruga et al., 1996) . Grb2 binding proteins in the cells might also in¯uence or regulate the amount of Grb2 associated with Sos, which may in turn in¯uence the activation of Ras pathway by the growth factor.
We have shown that Dab2 associates with Grb2 in vivo and in vitro. The binding is mediated through the proline-rich sequences of Dab2 and is presumed to involve the cooperative binding of both SH3 domains of Grb2. While the N-terminal regions of Dab2 and dDab show signi®cant homology (all contain the PID domain), the C-terminal proline-rich domain of Dab2 diers signi®cantly from that of dDab (Xu et al., 1995) . However, the C-terminal half of dDab also contains several stretches of proline-rich sequences, which might function analogously to those in Dab2. Thus, it is possible that dDab binds to a homologous SH3-containing Drosophila protein such as the Grb2 homolog Drk2. To our knowledge, this question has not been investigated. Our ®nding that Dab2 binds to Grb2 through the interaction of SH3 domains and proline-rich sequences may provide clues to the function of the Dab2 protein and to the further understanding of Grb2. Grb2 is composed of one SH2 and two SH3 domains, and it serves as an adaptor protein to attach cellular proteins to the tyrosine kinase receptor (Chardin et al., 1995; Downward 1994) . Although recent studies indicated that the recruitment model is over-simpli®ed (McCollam et al., 1995; Byrne et al., 1996; Chen et al., 1997) , the general thought is that the SH2 domain of Grb2 senses and binds the phosphorylated tyrosine residue of the activated receptor. The signalling proteins, the partners of Grb2, which are bound to the two SH3 domains of Grb2, are then recruited to the receptor. Thus, one possibility is that Dab2 is a component in a signalling pathway which links growth factor receptors with down-stream components. However, despite many attempts, we have failed to detect the association of Dab2 with the CSF-1 receptor or the EGF receptor (data not shown), although signi®cant quantities of Grb2 are associated in vivo with Dab2. Thus, unlike Sos, Dab2 is a Grb2 binding protein that is not recruited to a growth factor receptor upon growth factor receptor activation. One possibility, as suggested by experiments shown in Figure 7 , is that binding of tyrosine phosphorylated receptor to the SH2 domain of Grb2 decreases its anity to Dab2, but not to Sos. Although it was reported that the SH2 and SH3 domains of Grb2 act independently when small peptide ligands were used (Cussac et al., 1994; Lemmon et al., 1994) , recent experiments indicate that ligand binding of Grb2 SH2 in¯uences ligand binding of its SH3 domains to Sos (Ravichandran et al., 1995) . Although we have shown that phosphotyrosine peptide ligand binding to Grb2 decreases its binding to Dab2, we did not observe a decrease in Grb2/Dab2 complex when cells are stimulated with CSF-1 (Figure 2 ). It is likely that a small fraction of Grb2 complex is recruited to the receptor. Consistently, in lysate of CSF-1 stimulated cells, Grb2, Sos and Dab2 levels are not signi®cantly altered after immuno-depletion of CSF-1 receptor in which Grb2/Sos associated with the CSF-1 receptor is also depleted (data not shown).
Another possible function of Dab2 with regard to its Grb2 binding is that Dab2 may sequester Grb2 and Figure 7 Eect of phosphopeptide on Grb2 binding to Sos and Dab2. (a) Cellular Grb2/Sos, but not Grb2/Dab2 complex, binds to phosphopeptide PY488. Phosphopeptide PY488 was conjugated to A-gel 10 beads (about 0.01 mg peptide per ml of gel). Agarose carrier beads (30 ml) were mixed with 0, 5, 20 and 100 ml of PY 488 peptide-conjugated beads, and incubated with 1 ml BAC1.2F5 cell lysate (5 mg protein) at 48C for 1 h. The beads were washed three times with the Lysis Buer and boiled in SDS gel loading buer. An aliquot of the total cell lysate and the protein bound to the beads were analysed by Western blotting to determine the level of Sos, Dab2 and Grb2. (b) PY488 phosphopeptide inhibits GST-Grb2 binding to Dab2. Phosphopeptide PY488 (0, 1, 10, and 100 mM) or non-phosphorylated peptide Y488 (100 mM) were incubated with 1 ml of BAC1.2F5 cell lysate (5 mg protein) and 20 ml of beads conjugated with GST-Grb2. The beads were collected by centrifugation and washed with lysis buer for three times. The amounts of Sos and Dab2 bound to GST-Grb2 beads were analysed by Western blotting. Antibodies to Sos and Dab2 were mixed in the same incubation to detect both Sos and Dab2 on the same blot Dab2 binds Grb2 in vitro and in vivo X-X Xu et al serve as a reservoir for Grb2, and may therefore regulate the availability of Grb2 for binding to Sos. The data presented herein indicate that Dab2 competes with Sos for Grb2 binding, making this a plausible but unproven hypothesis. Consistent with this suggestion, recent studies indicate that the association of Grb2 with Sos is regulated (Cherniak et al., 1995; Waters et al., 1995; de Vries-Smits et al., 1995; Por®ri and McCormick, 1996; Langlois et al., 1996; Buday et al., 1995) . Activation of the Ras-MAP Kinase pathway leads to hyperphosphorylation of Sos which in turn causes it to dissociate from Grb2 (Cherniak et al., 1995; Waters et al., 1995; de Vries-Smits et al., 1995; Por®ri and McCormick, 1996; Langlois et al., 1996; Buday et al., 1995) . Such a dissociation may serve as a feedback down regulation mechanism for the Sos/Ras pathway, or might free Grb2 for other functions. Previous reports suggested that the dissociation of hyperphosphorylated Sos from Grb2 requires an additional cellular factor (Waters et al., 1995) , and it is possible that Dab2 may function in this capacity.
Regulation by Dab2 of the association between Grb2 and Sos would be expected to aect the activation of Ras, and might therefore be expected to serve as a negative regulator of Ras activation. Studies are in progress to evaluate this exciting possibility. 
Materials and methods
Materials
Cell cultures
BAC1.2F5 cells were maintained in 25% L cell conditioned medium as previously described (Xu et al., 1993 (Xu et al., , 1995 . Human kidney ®broblast 293 cells were kindly provided by Dr David Pallas (Emory University) and were cultured in DMEM with 10% fetal bovine serum supplemented with 1% non-essential amino acids, and 1 unit/ml penicillin/ streptomycin.
Antibodies, immunoblotting and immunoprecipitation
The Dab2 antiserum was prepared by immunizing rabbits with the N-terminal Dab2 peptide (M1: MSNEVET-SATNGQPDQQA). This antiserum recognizes both murine and human Dab2 (Xu et al., 1995; Albertsen et al., 1996) . A dilution of 1/2000 was used for immunoblotting and 10 ml/ml was used for immunoprecipitation. AntiGrb2 antiserum was prepared by immunizing rabbits with a peptide (ACHGQTMFPRNYVTPVNRNV); the antiserum to CSF-1 receptor (Fms) was a kind gift from Dr Martine Roussel (St Jude Children's Research Hospital, Memphis, TN). Other antibodies and their dilutions used for Western blotting were: anti-Grb2 monoclonal antibodies (1/1000 dilution, Signal Transduction Laboratories, Lexington, KY); anti-Sos1 monoclonal antibodies (1/1000, dilution, Santa Cruz Biotechnology Inc., Santa Cruz, CA); anti-Sos1/2 polyclonal rabbit antibodies (20 ml/ml for immunoprecipitation, Santa Cruz). Monolayers of cells in 100 mm plates were washed with cold phosphate-buered saline (PBS) and were lysed in 1 ml of the Lysis Buer [1% NP-40, 150 mM NaCl, 30 mM NaF, 50 mM Tris-HCl, pH 8.0, 1 mM NaVO 4 10 mM EDTA, and a protease inhibitor cocktail (1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mg/ml pepstatin)]. The post-nuclear supernatant was incubated with speci®c antibodies (10 ± 20 ml/ml) for 2 h at 48C. Protein Aconjugated Sepharose beads (50 ml of a 50% suspension) were added, and the mixtures were incubated for another hour. The beads were washed three times with lysis buer by centrifugation. Pre-immune serum (when available) or irrelevant antibodies were used as controls. Proteins bound to the beads were boiled for 5 min in SDS sample buer and subjected to Western blot analysis. Proteins from immunoprecipitation or cell lysates were fractionated using 7.5% polyacrylamide SDS PAGEs for immunoblotting with anti-Dab2 and Sos antibodies, and 12% gels for blotting with anti-Grb2 antibodies. Following electrophoresis, proteins in the gels were electro-transferred onto nitrocellulose membranes.
For Western blot analysis, the nitrocellulose blots were ®rst blocked by incubating in 2% dry milk in Tris-buered aline (TBS) with 0.05% NaN3 at room temperature for 1 h. The membranes were then incubated with speci®c antibodies (anti-Grb2, Sos, or Dab2) at room temperature for 2 ± 4 h or at 48C overnight. The membranes were then washed with TBS with 0.05% Tween-20 for three times, 5 min each. Secondary antibodies (donkey anti-rabbit or mouse IgG, conjugated with horseradish peroxidase) were added and incubated at room temperature for another hour. The membranes were then washed ®ve times with TBS and 0.05% Tween-20, soaked in ECL reagent and exposed to ®lms.
Preparation of GST fusion proteins
The human Grb2 cDNA was obtained by RT-PCR and inserted into pGEX2T vector (Pharmacia Biotechnology). The GST fusion proteins were expressed and prepared from E. coli (Yi et al., 1991 (Yi et al., , 1993 . The Grb2 SH2 domain fusion protein construct was prepared by PCR using the Grb2 cDNA as templates. The expression constructs containing the N-SH3 (amino acids #1-136) or C-SH3 domains (amino acids #135-217) of Grb2 were prepared by splicing the Grb2 cDNA by restriction digestion with Bgl II at the SH2 domain (nucleic acid #485). The full length Grb2, SH2, C-SH3 and N-SH3 domain fusion proteins, and GST control, were expressed and anity puri®ed by binding to glutathione-conjugated Sepharose beads. DNA constructs for GST fusion proteins of the phosphotyrosine interacting domain (PID, amino acids #1-233), middle region (M15, amino acids #335-610), and proline-rich domain (PRD, amino acids #600-730) of Dab2 were prepared by PCR using the cDNA as template. The fusion proteins were also expressed and puri®ed using glutathione-conjugated beads. An aliquot of each puri®ed GST fusion protein (about 10 mg) was analysed for purity by staining the gel with Coomassie Blue. All constructs were con®rmed by DNA sequencing using USB sequencing kit (Amersham).
GST fusion protein binding assay
A post-nuclear lysate was prepared from cells lysed in the Lysis Buer. The lysate was incubated with an aliquot (about 20 mg protein) of the puri®ed, glutathione-Sepharose bead-immobilized GST, GST-Grb2 or other fusion protein at 48C for 2 h. The beads were washed three times with lysis buer by centrifugation and boiled in SDS gel loading buer. An aliquot of the lysate supernatant and the pellet-bound proteins were subjected to Western blot analysis. The binding of cellular Dab2 and Sos to GSTGrb2 beads was also measured in the presence of increasing concentrations of the proline-rich peptide (PRP) added to the cell lysate prior to the addition of GST-Grb2. The peptides, Dab2-PRP, amino acids #661-669 (PPLVPSRKGC), or Sos-PRP, amino acids #1146-1161 (TDEVPVPPPPVPPRRR), were used to compete for binding to GST-Grb2.
Transfection and transient expression
Human kidney ®broblasts, 293 cells, were transfected with the pcDNA3 vector (Invitrogen, Carlsbad, CA) alone or with Dab2 cDNA insert using Lipofectamine according to the manufacturer's instructions. Brie¯y, vector and pCDNA3-Dab2 plasmid DNA was puri®ed by Qiagen columns. Plasmid DNA (2 mg/ml) and Lipofectamine (5 mg/ml) in Opti-MEM medium were incubated with 80% con¯uent monolayers for 12 h. Two days after transfection, the cells were lysed with the Lysis Buer, and the lysates (15 mg protein in 1 ml) were used for immunoprecipitation experiments using anti-Grb2 antibodies. The immunocomplexes were analysed for Grb2, Dab2 and Sos by Western blotting.
Phosphopeptide and conjugate
Eight oligopeptides and phosphopeptides corresponding to cytoplasmic domain of erythropoietin receptor were prepared as described in a previous report (Yi et al., 1995) . The sequence of Y488 is SHPYENSLVPD, corresponding to amino acid #485-495 of murine erythropoietin receptor. In PY 488 peptide, the tyrosine #488 is substituted with a phosphotyrosine. The phosphopeptide was conjugated to A-gel 10 beads (Bio-Rad Laboratories, Richmond, CA), and it was determined that about 0.01 mg of peptide was conjugated in 1 ml of beads.
Abbreviations c-Fms, CSF-1 receptors; CSF-1, Colony-stimulating Factor 1; DMEM, Dulbeco's modi®ed Eagle's Medium; EGF, epidermal Growth Factor; FBS, fetal bovine serum; Grb2, Growth Factor Receptor Binding Protein 2; GST, glutathione S transferase; NS, non-synchronized; PBS, phosphate-buered saline; PDGF, platelet derived growth factor; PMSF, phenylmethylsulfonyl¯uoride; PRD, proline-rich domain; PRP, proline-rich peptide; PID (or PTB), phosphotyrosine interaction domain; SH2 and SH3, src homology domain 2 and 3; Sos, Son of Sevenless; TSB, Tris-buered saline.
